Search
for
Sort by
Research 61–90 of 1000+
- Beyond acne: Current aspects of sebaceous gland biology and function
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Nonclassic adrenal hyperplasia
- Profiling the Response of Human Hair Follicles to Ultraviolet Radiation
- Prolactin delays hair regrowth in mice
- Exploring the “Thyroid–Skin Connection”: Concepts, Questions, and Clinical Relevance
- Idiopathic Hirsutism*
- Hormonal treatment of acne vulgaris: an update
- Endocrine-skin interactions
- Down-regulation of Melanocortin Receptor Signaling Mediated by the Amino Terminus of Agouti Protein in XenopusMelanophores
- Role of insulin resistance and diet in acne
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Endocrinological evaluation and hormonal therapy for women with difficult acne
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Androgen antagonists in androgen target tissues
- Hormonal therapies for acne
- Hormone therapy in acne
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Congenital adrenal hyperplasia
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Targets to treat androgen excess in polycystic ovary syndrome
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Anti-androgen therapy in dermatology: a review
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Steroid Hormones